Clinical Trial Update: Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aliskiren/amlodipine and amlodipine on ankle-foot volume in hypertension was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Peripheral Edema

Drugs mentioned

• Amlodipine (amlodipine)
• Tekamlo (aliskiren/amlodipine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension, Ankle Edema | Phase 2 | Status: TERMINATED | Results posted: 2011-12-26